Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors while in the central nervous system, conolidine modulates alternate molecular targets. A Science Advances review observed that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://stephenmmfyu.blogerus.com/59658015/not-known-factual-statements-about-alternative-natural-pain-relief-to-replace-traditional-painkillers